Herpecare
Commercial- Indications
- Genital herpes
Company intelligence / Profile preview
Laboratoires Carilene
Montesson, Île-de-France, Francecarilene.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Laboratoires Carilene has developed HERPECARE, a gel indicated for the functional symptoms of recurrent genital herpes. A randomized multicenter comparative study was conducted in 2011 to evaluate its efficacy and safety. The company also specializes in the industrialization of controlled oxidation processes for vegetable oils over the last thirty years.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Small moleculeGel-based therapy
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Pure Source Inc.
Beyond the preview
Go deeper on Laboratoires Carilene.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Laboratoires Carilene.